Firdapse
amifampridine phosphate
Listed by Catalyst Pharmaceuticals, Inc.
- Strength
- 10 mg/1
- Form
- Tablet
- Route
- Oral
- Class
- Potassium Channel Blocker
What it contains
- Amifampridine Phosphate 10 mg/1
FDA record
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Potassium Channel Blocker |
| Approval route | NDA — original brand approval |
| NDC code | 69616-211 |
| FDA application | NDA208078 |
| RxNorm concept | 2106343 |
| Package sizes listed | 3 |
| Marketed since | January 2019 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.